Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation.

Petrelli A, Mijnheer G, Hoytema van Konijnenburg DP, van der Wal MM, Giovannone B, Mocholi E, Vazirpanah N, Broen JC, Hijnen D, Oldenburg B, Coffer PJ, Vastert SJ, Prakken BJ, Spierings E, Pandit A, Mokry M, van Wijk F.

J Clin Invest. 2018 Oct 1;128(10):4669-4681. doi: 10.1172/JCI96107. Epub 2018 Aug 2.

2.

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.

Chouri E, Servaas NH, Bekker CPJ, Affandi AJ, Cossu M, Hillen MR, Angiolilli C, Mertens JS, van den Hoogen LL, Silva-Cardoso S, van der Kroef M, Vazirpanah N, Wichers CGK, Carvalheiro T, Blokland SLM, Giovannone B, Porretti L, Marut W, Vigone B, van Roon JAG, Beretta L, Rossato M, Radstake TRDJ.

J Autoimmun. 2018 May;89:162-170. doi: 10.1016/j.jaut.2017.12.015. Epub 2018 Jan 20.

3.

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice.

Hoeke G, Khedoe PPSJ, van Diepen JA, Pike-Overzet K, van de Ven B, Vazirpanah N, Mol I, Hiemstra PS, Staal FJT, Stienstra R, Netea MG, Dinarello CA, Rensen PCN, Berbée JFP.

Int J Mol Sci. 2017 Aug 9;18(8). pii: E1672. doi: 10.3390/ijms18081672.

4.

Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?

Schuiveling M, Vazirpanah N, Radstake TRDJ, Zimmermann M, Broen JCA.

Curr Drug Targets. 2018;19(8):945-959. doi: 10.2174/1389450118666170613081730.

PMID:
28606032
5.

Aberrant leukocyte telomere length in Birdshot Uveitis.

Vazirpanah N, Verhagen FH, Rothova A, Missotten TOAR, van Velthoven M, Den Hollander AI, Hoyng CB, Radstake TRDJ, Broen JCA, Kuiper JJW.

PLoS One. 2017 May 1;12(5):e0176175. doi: 10.1371/journal.pone.0176175. eCollection 2017.

6.

Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout.

Vazirpanah N, Kienhorst LBE, Van Lochem E, Wichers C, Rossato M, Shiels PG, Dalbeth N, Stamp LK, Merriman TR, Janssen M, Radstake TRDJ, Broen JC.

Ann Rheum Dis. 2017 Jul;76(7):1313-1319. doi: 10.1136/annrheumdis-2016-210538. Epub 2017 Mar 27.

PMID:
28347991
7.

Inflamm-ageing and Senescence in Gout: The Tale of an Old King's Disease.

Vazirpanah N, Radstake TR, Broen JC.

Curr Aging Sci. 2015;8(2):186-201. Review.

PMID:
26212054
8.

Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.

Berbée JF, Boon MR, Khedoe PP, Bartelt A, Schlein C, Worthmann A, Kooijman S, Hoeke G, Mol IM, John C, Jung C, Vazirpanah N, Brouwers LP, Gordts PL, Esko JD, Hiemstra PS, Havekes LM, Scheja L, Heeren J, Rensen PC.

Nat Commun. 2015 Mar 10;6:6356. doi: 10.1038/ncomms7356.

Supplemental Content

Loading ...
Support Center